Cucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expression

Abstract Background Melanoma is among the most aggressive types of skin malignancy and can have an unpredictable clinical course. Exploration of novel therapeutic targets and their regulators remains essential for the prevention and treatment of melanoma. Methods HSDL2 protein levels were examined b...

Full description

Bibliographic Details
Main Authors: Wen-Bei Liu, He-Li Wang, Lei Chen, Biao Tang, Guolin Ke, Shuai Wang, Yin-Qiao Sun, Junting Ma, Da-Lun Lyu
Format: Article
Language:English
Published: BMC 2022-02-01
Series:Chinese Medicine
Subjects:
Online Access:https://doi.org/10.1186/s13020-022-00582-y
_version_ 1830405176891015168
author Wen-Bei Liu
He-Li Wang
Lei Chen
Biao Tang
Guolin Ke
Shuai Wang
Yin-Qiao Sun
Junting Ma
Da-Lun Lyu
author_facet Wen-Bei Liu
He-Li Wang
Lei Chen
Biao Tang
Guolin Ke
Shuai Wang
Yin-Qiao Sun
Junting Ma
Da-Lun Lyu
author_sort Wen-Bei Liu
collection DOAJ
description Abstract Background Melanoma is among the most aggressive types of skin malignancy and can have an unpredictable clinical course. Exploration of novel therapeutic targets and their regulators remains essential for the prevention and treatment of melanoma. Methods HSDL2 protein levels were examined by immunohistochemistry. The roles of HSDL2 in cell proliferation and apoptosis were identified by CCK-8 and colony formation assays. The function of HSDL2 in cell apoptosis was analysed by flow cytometry. Western blotting, cell proliferation and apoptosis and a xenograft tumour model were utilized to explore the inhibitory functions and mechanisms of CuE in melanoma. Results HSDL2 is overexpressed in melanoma and promotes melanoma progression by activating the ERK and AKT pathways. CuE could inhibit the ERK and AKT pathways by decreasing HSDL2 expression; therefore, CuE could inhibit melanoma growth in vitro and in vivo. Conclusion HSDL2 may be a promising therapeutic target against melanoma, and CuE can inhibit melanoma by downregulating HSDL2 expression.
first_indexed 2024-12-20T17:40:46Z
format Article
id doaj.art-61d8ec7d5e184a8591d9ceee734e9025
institution Directory Open Access Journal
issn 1749-8546
language English
last_indexed 2024-12-20T17:40:46Z
publishDate 2022-02-01
publisher BMC
record_format Article
series Chinese Medicine
spelling doaj.art-61d8ec7d5e184a8591d9ceee734e90252022-12-21T19:31:06ZengBMCChinese Medicine1749-85462022-02-0117111110.1186/s13020-022-00582-yCucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expressionWen-Bei Liu0He-Li Wang1Lei Chen2Biao Tang3Guolin Ke4Shuai Wang5Yin-Qiao Sun6Junting Ma7Da-Lun Lyu8Department of Dermato-Venerology and Department of Burn and Plastic Surgery, The First Affiliated Hospital of Wannan Medical CollegeDepartment of Dermato-Venerology and Department of Burn and Plastic Surgery, The First Affiliated Hospital of Wannan Medical CollegeDepartment of Dermato-Venerology and Department of Burn and Plastic Surgery, The First Affiliated Hospital of Wannan Medical CollegeDepartment of Dermato-Venerology and Department of Burn and Plastic Surgery, The First Affiliated Hospital of Wannan Medical CollegeDepartment of Dermato-Venerology and Department of Burn and Plastic Surgery, The First Affiliated Hospital of Wannan Medical CollegeDepartment of Dermato-Venerology and Department of Burn and Plastic Surgery, The First Affiliated Hospital of Wannan Medical CollegeDepartment of Dermato-Venerology and Department of Burn and Plastic Surgery, The First Affiliated Hospital of Wannan Medical CollegeDepartment of Pharmacology, School of Basic Medical Sciences, Anhui Medical UniversityDepartment of Dermato-Venerology and Department of Burn and Plastic Surgery, The First Affiliated Hospital of Wannan Medical CollegeAbstract Background Melanoma is among the most aggressive types of skin malignancy and can have an unpredictable clinical course. Exploration of novel therapeutic targets and their regulators remains essential for the prevention and treatment of melanoma. Methods HSDL2 protein levels were examined by immunohistochemistry. The roles of HSDL2 in cell proliferation and apoptosis were identified by CCK-8 and colony formation assays. The function of HSDL2 in cell apoptosis was analysed by flow cytometry. Western blotting, cell proliferation and apoptosis and a xenograft tumour model were utilized to explore the inhibitory functions and mechanisms of CuE in melanoma. Results HSDL2 is overexpressed in melanoma and promotes melanoma progression by activating the ERK and AKT pathways. CuE could inhibit the ERK and AKT pathways by decreasing HSDL2 expression; therefore, CuE could inhibit melanoma growth in vitro and in vivo. Conclusion HSDL2 may be a promising therapeutic target against melanoma, and CuE can inhibit melanoma by downregulating HSDL2 expression.https://doi.org/10.1186/s13020-022-00582-yMelanomaHSDL2Cucurbitacin EERK and AKT pathwaysProliferation and apoptosis
spellingShingle Wen-Bei Liu
He-Li Wang
Lei Chen
Biao Tang
Guolin Ke
Shuai Wang
Yin-Qiao Sun
Junting Ma
Da-Lun Lyu
Cucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expression
Chinese Medicine
Melanoma
HSDL2
Cucurbitacin E
ERK and AKT pathways
Proliferation and apoptosis
title Cucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expression
title_full Cucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expression
title_fullStr Cucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expression
title_full_unstemmed Cucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expression
title_short Cucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expression
title_sort cucurbitacin e inhibits cellular proliferation and induces apoptosis in melanoma by suppressing hsdl2 expression
topic Melanoma
HSDL2
Cucurbitacin E
ERK and AKT pathways
Proliferation and apoptosis
url https://doi.org/10.1186/s13020-022-00582-y
work_keys_str_mv AT wenbeiliu cucurbitacineinhibitscellularproliferationandinducesapoptosisinmelanomabysuppressinghsdl2expression
AT heliwang cucurbitacineinhibitscellularproliferationandinducesapoptosisinmelanomabysuppressinghsdl2expression
AT leichen cucurbitacineinhibitscellularproliferationandinducesapoptosisinmelanomabysuppressinghsdl2expression
AT biaotang cucurbitacineinhibitscellularproliferationandinducesapoptosisinmelanomabysuppressinghsdl2expression
AT guolinke cucurbitacineinhibitscellularproliferationandinducesapoptosisinmelanomabysuppressinghsdl2expression
AT shuaiwang cucurbitacineinhibitscellularproliferationandinducesapoptosisinmelanomabysuppressinghsdl2expression
AT yinqiaosun cucurbitacineinhibitscellularproliferationandinducesapoptosisinmelanomabysuppressinghsdl2expression
AT juntingma cucurbitacineinhibitscellularproliferationandinducesapoptosisinmelanomabysuppressinghsdl2expression
AT dalunlyu cucurbitacineinhibitscellularproliferationandinducesapoptosisinmelanomabysuppressinghsdl2expression